+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Rx/Reimbursement Adult Incontinence in Argentina

  • PDF Icon

    Report

  • 19 Pages
  • February 2024
  • Region: Argentina
  • Euromonitor International
  • ID: 5129219
The National Institute of Social Services for Retirees and Pensioners (PAMI) is the public institution charged with providing healthcare coverage to elderly people in Argentina, a remit that includes the distribution of Rx/reimbursement adult incontinence products. Operating via a nationwide network of 650 subsidiaries, it has approximately 4.8 million members, around 700,000 of whom live in the city of Buenos Aires.

The Rx/Reimbursement adult incontinence in Argentina report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2019-2023, allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market – be they new product developments, distribution or pricing issues. Forecasts to 2028 illustrate how the market is set to change.

Data coverage: Market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?

  • Get a detailed picture of the Rx/Reimbursement adult incontinence market;
  • Pinpoint growth sectors and identify factors driving change;
  • Understand the competitive environment, the market’s major players and leading brands;
  • Use five-year forecasts to assess how the market is predicted to develop.

Table of Contents

RX/REIMBURSEMENT ADULT INCONTINENCE IN ARGENTINAKEY DATA FINDINGS
2023 DEVELOPMENTS
  • PAMI retains overall responsibility for distribution of Rx/reimbursement products
  • Return to the previous distribution scheme
  • Only two companies serve as PAMI providers
PROSPECTS AND OPPORTUNITIES
  • Price adjustment by PAMI anticipated
  • Increasing pressure on public finances due to ageing population
  • Skin care considerations and PAMI's priorities
CATEGORY DATA
  • Table 1 Sales of Rx/Reimbursement Adult Incontinence: Total Value MSP 2018-2023
  • Table 2 Sales of Rx/Reimbursement Adult Incontinence: Total Value MSP Growth 2018-2023
  • Table 3 Forecast Sales of Rx/Reimbursement Adult Incontinence: Total Value MSP 2023-2028
  • Table 4 Forecast Sales of Rx/Reimbursement Adult Incontinence: Total Value MSP Growth 2023-2028
TISSUE AND HYGIENE IN ARGENTINA
EXECUTIVE SUMMARY
  • Tissue and hygiene in 2023: The big picture
  • 2023 key trends
  • Competitive landscape
  • Retailing developments
  • What next for tissue and hygiene?
MARKET INDICATORS
  • Table 5 Birth Rates 2018-2023
  • Table 6 Infant Population 2018-2023
  • Table 7 Female Population by Age 2018-2023
  • Table 8 Total Population by Age 2018-2023
  • Table 9 Households 2018-2023
  • Table 10 Forecast Infant Population 2023-2028
  • Table 11 Forecast Female Population by Age 2023-2028
  • Table 12 Forecast Total Population by Age 2023-2028
  • Table 13 Forecast Households 2023-2028
MARKET DATA
  • Table 14 Retail Sales of Tissue and Hygiene by Category: Value 2018-2023
  • Table 15 Retail Sales of Tissue and Hygiene by Category: % Value Growth 2018-2023
  • Table 16 NBO Company Shares of Retail Tissue and Hygiene: % Value 2019-2023
  • Table 17 LBN Brand Shares of Retail Tissue and Hygiene: % Value 2020-2023
  • Table 18 Penetration of Private Label in Retail Tissue and Hygiene by Category: % Value 2018-2023
  • Table 19 Distribution of Retail Tissue and Hygiene by Format: % Value 2018-2023
  • Table 20 Distribution of Retail Tissue and Hygiene by Format and Category: % Value 2023
  • Table 21 Forecast Retail Sales of Tissue and Hygiene by Category: Value 2023-2028
  • Table 22 Forecast Retail Sales of Tissue and Hygiene by Category: % Value Growth 2023-2028
DISCLAIMER
SOURCES
  • Summary 1 Research Sources